Investors in ImmunoCellular Therapeutics Ltd (IMUC) saw new options become available this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IMUC options chain for the new September 21st contracts and identified the following call contract of particular interest.The call contract at the $2.50 strike price has a current bid of 20 cents. If an investor was to purchase shares of IMUC stock at the current price level of $2.35/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock at $2.50. Considering the call seller will also collect the premium, that would drive a total return (excluding dividends, if any) of 14.89% if the stock gets called away at the September 21st expiration (before broker commissions). Of course, a lot of upside could potentially be left on the table if IMUC shares really soar, which is why looking at the trailing twelve month trading history for ImmunoCellular Therapeutics Ltd, as well as studying the business fundamentals becomes important. Below is a chart showing IMUC's trailing twelve month trading history, with the $2.50 strike highlighted in red:
First Week Of September 21st Options Trading For ImmunoCellular Therapeutics (IMUC)
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.